GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy shows promise for tough brain tumors
Disease control OngoingThis study tests two immunotherapy drugs, ipilimumab and nivolumab, in 37 adults with recurrent glioblastoma (a severe brain cancer) that has many genetic mutations. The goal is to see if these drugs can shrink or slow the tumor better than standard treatments like surgery or che…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug targets brain tumors and lung cancer spread
Disease control OngoingThis early-phase trial tests a drug called WSD0922-FU in about 56 people with certain brain cancers (glioblastoma, anaplastic astrocytoma) or lung cancer that has spread to the brain or spinal cord. The drug blocks a protein called EGFR, which helps some cancers grow. The main go…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could a transplant drug help fight brain cancer?
Disease control OngoingThis early-phase trial tests the safety and best dose of mycophenolate mofetil, a drug usually used to prevent organ rejection, when added to standard chemotherapy and radiation for glioblastoma. About 60 adults with newly diagnosed or recurrent glioblastoma will take part. The g…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Sound waves punch holes in Brain's shield to attack deadly tumors
Disease control OngoingThis trial tests a device implanted in the skull that uses ultrasound to temporarily open the blood-brain barrier, allowing chemotherapy drugs to reach brain tumors more effectively. About 57 adults with recurrent glioblastoma will receive this treatment after surgery to remove t…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC